1. Home
  2. GOOS vs SYRE Comparison

GOOS vs SYRE Comparison

Compare GOOS & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOOS
  • SYRE
  • Stock Information
  • Founded
  • GOOS 1957
  • SYRE 2013
  • Country
  • GOOS Canada
  • SYRE United States
  • Employees
  • GOOS N/A
  • SYRE N/A
  • Industry
  • GOOS
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • GOOS
  • SYRE Health Care
  • Exchange
  • GOOS Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • GOOS 822.8M
  • SYRE 841.4M
  • IPO Year
  • GOOS 2017
  • SYRE 2016
  • Fundamental
  • Price
  • GOOS $8.79
  • SYRE $14.10
  • Analyst Decision
  • GOOS Sell
  • SYRE Buy
  • Analyst Count
  • GOOS 5
  • SYRE 8
  • Target Price
  • GOOS $9.50
  • SYRE $50.00
  • AVG Volume (30 Days)
  • GOOS 721.9K
  • SYRE 553.9K
  • Earning Date
  • GOOS 05-21-2025
  • SYRE 05-08-2025
  • Dividend Yield
  • GOOS N/A
  • SYRE N/A
  • EPS Growth
  • GOOS 51.35
  • SYRE N/A
  • EPS
  • GOOS 0.51
  • SYRE N/A
  • Revenue
  • GOOS $917,088,739.00
  • SYRE N/A
  • Revenue This Year
  • GOOS $0.91
  • SYRE N/A
  • Revenue Next Year
  • GOOS $4.46
  • SYRE N/A
  • P/E Ratio
  • GOOS $16.64
  • SYRE N/A
  • Revenue Growth
  • GOOS 4.16
  • SYRE N/A
  • 52 Week Low
  • GOOS $6.73
  • SYRE $10.91
  • 52 Week High
  • GOOS $14.75
  • SYRE $40.49
  • Technical
  • Relative Strength Index (RSI)
  • GOOS 59.93
  • SYRE 48.32
  • Support Level
  • GOOS $8.15
  • SYRE $12.29
  • Resistance Level
  • GOOS $8.49
  • SYRE $15.77
  • Average True Range (ATR)
  • GOOS 0.25
  • SYRE 1.06
  • MACD
  • GOOS 0.08
  • SYRE 0.08
  • Stochastic Oscillator
  • GOOS 98.07
  • SYRE 52.08

About GOOS Canada Goose Holdings Inc. Subordinate Voting Shares

Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale and Direct to Consumer (DTC), Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of functional and fashionable retailers, including major luxury department stores, outdoor specialty stores, individual shops, and international distributors. Geographically, it has a presence in Canada, the United States, Asia, Europe, and the Rest of the World.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: